Internal Medicine · Englewood, FL
NPI
1205043536
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
601 Medical Dr
Englewood, FL, 34223
Phone (941) 475-5621
Groups this clinician bills Medicare through
Medicare paid, 2024
$339K
5,557 services
Medicare patients, 2024
1,035
Average age 78
Drug cost, 2024
$1.5M
6,662 prescriptions
Company payments, 2025
$54.67
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sailendra Upendram was code 93298 (external electrocardiographic monitoring), 843 times for 94 patients. In total Sailendra Upendram billed 5,557 services in 71 codes, and Medicare paid $339K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93298 External Electrocardiographic Monitoring | Office | 843 | 94 | $20.45 | $17K |
| 99214 Office E&M - Established | Office | 655 | 493 | $96.03 | $63K |
| 93000 Electrocardiogram | Office | 651 | 520 | $10.85 | $7,064 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 344 | 86 | $5.59 | $1,924 |
| 93010 Electrocardiogram | Facility | 263 | 152 | $6.23 | $1,637 |
| 93306 Echocardiography (TTE/TEE) | Office | 261 | 258 | $125.08 | $33K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 234 | 117 | $92.40 | $22K |
| 99211 Office E&M - Established | Office | 232 | 41 | $16.18 | $3,753 |
| 85610 Clinical Chemistry | Office | 221 | 29 | $4.20 | $928 |
| 99152 Anesthesia | Facility | 190 | 183 | $9.59 | $1,822 |
| 93306 Echocardiography (TTE/TEE) | Facility | 166 | 163 | $52.14 | $8,656 |
| 99223 Hospital E&M - Initial | Facility | 142 | 142 | $134.35 | $19K |
| 93294 External Electrocardiographic Monitoring | Office | 133 | 74 | $20.23 | $2,691 |
| 99233 Hospital E&M - Subsequent | Facility | 122 | 73 | $83.20 | $10K |
| 93015 Electrocardiogram | Office | 117 | 117 | $47.57 | $5,565 |
By year: 2022 $459K for 6,946 services; 2023 $428K for 6,092 services; 2024 $339K for 5,557 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 221 | 29 | $4.20 | $928 |
Medicare prescription drug claims, 2024
In 2024, the drug Sailendra Upendram prescribed most often to Medicare patients was Metoprolol Succinate, with 726 prescriptions and refills. In total Sailendra Upendram wrote 6,662 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 726 | 2,127 | 244 | $9,843 |
| Eliquis Apixaban | 528 | 1,283 | 161 | $733K |
| Clopidogrel Clopidogrel Bisulfate | 498 | 1,439 | 158 | $5,697 |
| Atorvastatin Calcium Generic | 442 | 1,307 | 141 | $4,170 |
| Amlodipine Besylate Generic | 309 | 923 | 104 | $2,176 |
| Losartan Potassium Generic | 294 | 868 | 96 | $2,679 |
| Rosuvastatin Calcium Generic | 267 | 793 | 92 | $2,692 |
| Lisinopril Generic | 245 | 730 | 78 | $1,564 |
| Digoxin Generic | 244 | 697 | 83 | $6,252 |
| Ezetimibe Generic | 206 | 585 | 75 | $4,410 |
| Furosemide Generic | 194 | 512 | 72 | $921 |
| Carvedilol Generic | 191 | 537 | 67 | $1,586 |
| Repatha Sureclick Evolocumab | 182 | 410 | 47 | $232K |
| Pravastatin Sodium Generic | 176 | 509 | 57 | $2,372 |
| Metoprolol Tartrate Generic | 160 | 471 | 56 | $811 |
Brand drugs: 1,050 claims; generic drugs: 5,612 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sailendra Upendram $54.67 ($54.67 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novartis Pharmaceuticals Corporation with $24.01.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.